Replies to post #45562 on Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

Today is an EAPH buying day before Major News is announced this week in several areas that will place EAPH in a stronger position to be uplisted in early 2018. Easton's PPS is way undervalued at the current levels and will hit new 52-week highs. PPS will catch up with true value as acquisitions and joint venture partnerships close and revenues continue building.